Exploring the views of infection consultants in England on a novel delinked funding model for antimicrobials: the SMASH study

Ioannis Baltas*, Mark Gilchrist, Eirini Koutoumanou, Malick M Gibani, James E Meiring, Akaninyene Otu, David Hettle, Ameeka Thompson, James R Price, Anna Crepet, Abolaji Atomode, Timothy Crocker-Buque, Dimitrios Spinos, Hudson Guyver, Matija Tausan, Donald Somasunderam, Maxwell Thoburn, Cathleen Chan, Helen Umpleby, Bethany SharpCallum Chivers, Devan Suresh Vaghela, Ronak J Shah, Jonathan Foster, Amy Hume, Christopher Smith, Ammara Asif, Dimitrios Mermerelis, Mohammad Abbas Reza, Dominic A Haigh, Thomas Lamb, Loucia Karatzia, Alexandra Bramley, Nikhil Kadam, Konstantinos Kavallieros, Veronica Garcia-Arias, Jane Democratis, Claire S Waddington, Luke S P Moore, Alexander M Aiken

*Corresponding author for this work

Research output: Contribution to journalArticle (Academic Journal)peer-review

1 Citation (Scopus)

Fingerprint

Dive into the research topics of 'Exploring the views of infection consultants in England on a novel delinked funding model for antimicrobials: the SMASH study'. Together they form a unique fingerprint.

Agricultural and Biological Sciences

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry

Engineering